BONJESTA

Peak

doxylamine succinate and pyridoxine hydrochloride

NDAORALTABLET, EXTENDED RELEASE
Approved
Nov 2016
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

12.1 Mechanism of Action The mechanism of action of BONJESTA is unknown. 12.3 Pharmacokinetics The pharmacokinetics of BONJESTA has been characterized in healthy non-pregnant adult women. Absorption In a single-dose, crossover clinical trial conducted in 48 healthy, premenopausal women under…

Loss of Exclusivity

LOE Date
Feb 18, 2033
84 months away
Patent Expiry
Feb 18, 2033

Patent Records (4)

Patent #ExpiryTypeUse Code
9089489
Feb 18, 2033
Product
U-1382
9375404
Feb 18, 2033
Product
U-1382
9526703
Feb 18, 2033
Product
U-1382
9937132
Feb 18, 2033
Product
U-1382